These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20501943)

  • 21. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients.
    Böhmig GA; Säemann MD; Bergmann M; Watschinger B; Regele H; Windhager T; Mühlbacher F; Hörl WH; Zlabinger GJ
    Transpl Int; 2000; 13(3):187-93. PubMed ID: 10935701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.
    Morris H; DeWolf S; Robins H; Sprangers B; LoCascio SA; Shonts BA; Kawai T; Wong W; Yang S; Zuber J; Shen Y; Sykes M
    Sci Transl Med; 2015 Jan; 7(272):272ra10. PubMed ID: 25632034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.
    Massart A; Pallier A; Pascual J; Viklicky O; Budde K; Spasovski G; Klinger M; Sever MS; Sørensen SS; Hadaya K; Oberbauer R; Dudley C; De Fijter JW; Yussim A; Hazzan M; Wekerle T; Berglund D; De Biase C; Pérez-Sáez MJ; Mühlfeld A; Orlando G; Clemente K; Lai Q; Pisani F; Kandus A; Baas M; Bemelman F; Ponikvar JB; Mazouz H; Stratta P; Subra JF; Villemain F; Hoitsma A; Braun L; Cantarell MC; Colak H; Courtney A; Frasca GM; Howse M; Naesens M; Reischig T; Serón D; Seyahi N; Tugmen C; Alonso Hernandez A; Beňa L; Biancone L; Cuna V; Díaz-Corte C; Dufay A; Gaasbeek A; Garnier A; Gatault P; Gentil Govantes MA; Glowacki F; Gross O; Hurault de Ligny B; Huynh-Do U; Janbon B; Jiménez Del Cerro LA; Keller F; La Manna G; Lauzurica R; Le Monies De Sagazan H; Thaiss F; Legendre C; Martin S; Moal MC; Noël C; Pillebout E; Piredda GB; Puga AR; Sulowicz W; Tuglular S; Prokopova M; Chesneau M; Le Moine A; Guérif P; Soulillou JP; Abramowicz M; Giral M; Racapé J; Maggiore U; Brouard S; Abramowicz D
    Nephrol Dial Transplant; 2016 Jun; 31(6):1002-13. PubMed ID: 26763669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients.
    Ardalan MR; Maljaei H; Shoja MM; Piri AR; Khosroshahi HT; Noshad H; Argani H
    Transplant Proc; 2007 May; 39(4):951-3. PubMed ID: 17524860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-Cell Profiling of Kidney Transplant Recipients With Immunosuppressive Treatment Reveals the Dynamic Immune Characteristics.
    Liu Y; Liu X; Zhou S; Xu R; Hu J; Liao G; Liao J; Guo Z; Li Y; Yang S; Li S; Chen H; Guo Y; Li M; Fan L; Li L; Zhao M; Liu D
    Front Immunol; 2021; 12():639942. PubMed ID: 33959124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes.
    Dujardin A; Chesneau M; Dubois F; Danger R; Bui L; Kerleau C; Guérif P; Brouard S; Dantal J
    Kidney Int; 2021 Jun; 99(6):1418-1429. PubMed ID: 33137335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The mechanism of donor specific unresponsiveness in renal transplant recipients].
    Okimoto T; Yahata H; Fukuda Y; Dohi K
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):118-28. PubMed ID: 9754014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.
    Louis S; Braudeau C; Giral M; Dupont A; Moizant F; Robillard N; Moreau A; Soulillou JP; Brouard S
    Transplantation; 2006 Feb; 81(3):398-407. PubMed ID: 16477227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pits and pearls in translating operational tolerance biomarkers into clinical practice.
    Roedder S; Gao X; Sarwal MM
    Curr Opin Organ Transplant; 2012 Dec; 17(6):655-62. PubMed ID: 23080065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis.
    Braud C; Baeten D; Giral M; Pallier A; Ashton-Chess J; Braudeau C; Chevalier C; Lebars A; Léger J; Moreau A; Pechkova E; Nicolini C; Soulillou JP; Brouard S
    J Cell Biochem; 2008 Apr; 103(6):1681-92. PubMed ID: 17910029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients.
    Ng WF; Hernandez-Fuentes M; Baker R; Chaudhry A; Lechler RI
    J Am Soc Nephrol; 2002 Dec; 13(12):2983-9. PubMed ID: 12444218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
    Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
    J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance induced by anti-CD3 immunotoxin plus 15-deoxyspergualin associates with donor-specific indirect pathway unresponsiveness.
    Asiedu CK; Dong SS; Lobashevsky A; Jenkins SM; Thomas JM
    Cell Immunol; 2003 Jun; 223(2):103-12. PubMed ID: 14527508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection.
    Duizendstra AA; van der Grift MV; Boor PP; Noordam L; de Knegt RJ; Peppelenbosch MP; Betjes MGH; Litjens NHR; Kwekkeboom J
    Front Immunol; 2021; 12():738837. PubMed ID: 35087511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.
    Xu Q; Lee J; Jankowska-Gan E; Schultz J; Roenneburg DA; Haynes LD; Kusaka S; Sollinger HW; Knechtle SJ; VanBuskirk AM; Torrealba JR; Burlingham WJ
    J Immunol; 2007 Mar; 178(6):3983-95. PubMed ID: 17339499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients.
    Pérez-Flores I; Sánchez-Fructuoso A; Santiago JL; Fernández-Arquero M; Calvo N; de la Concha EG; Barrientos A
    Transplant Proc; 2009; 41(6):2106-8. PubMed ID: 19715845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.
    Baron D; Ramstein G; Chesneau M; Echasseriau Y; Pallier A; Paul C; Degauque N; Hernandez-Fuentes MP; Sanchez-Fueyo A; Newell KA; Giral M; Soulillou JP; Houlgatte R; Brouard S
    Kidney Int; 2015 May; 87(5):984-95. PubMed ID: 25629549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.